Summary : -Maharashtra health minister Rajesh Tope has inaugurated Bharat Serums and Vaccines (BSV)’s research and development centre at Airoli. -BSV, a…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Disorder
-
-
AgrochemicalsIndia
Haryana sets up most number of Ayurvedic Manufacturing Units in 2020-21
by adminby adminSynopsis: The State of Haryana has seen the highest number of new companies manufacturing ayurvedic medicines registered during the fiscal year 2020-21,…
-
AstraZenecaGlobal Market
AstraZeneca, Neurimmune Sign Exclusive Collaboration and License Agreement for NI006
by adminby adminSynopsis: Neurimmune AG, a biopharmaceutical company, announced that it has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca’s…
-
AgrochemicalsCovid DrugsIndia
Indomethacin highly efficacious in treating Covid infection: Study
by adminby adminIndomethacin is shown to be highly efficient in treating the Covid infection as per a study conducted by Dr Rajan Ravichandran, director…
-
Synopsis : This strain of the SARS-CoV-2 carries the N501Y mutation While the world is pulling in resources to fight back against…
-
AgrochemicalsGlobal Market
1000 Cr Approved by Wockhardt board to meet the Company’s Financing Needs
by adminby adminSynopsis: The objective of the issue is to meet the company’s financing needs for repayment of subordinated debt due, financing research and…
-
AgrochemicalsGlobal Market
AstraZeneca completes transfer of global rights to Eklira & Duaklir to Covis Pharma
by adminby adminSummary : AstraZeneca has completed the transfer of its global rights to Eklira (aclidinium bromide), known as Tudorza in the US, and…
-
RegulatoryU.S FDA
US FDA approves expanded MRI compatibility for Abbott’s Proclaim XR Spinal Cord Stimulation System
by adminby adminSummary : -Abbott, a global healthcare leader, announced that the US Food and Drug Administration (FDA) has approved new expanded magnetic resonance…
-
AgrochemicalsGlobal Market
Clover and Ascentage Pharma Announce Clinical Collaboration to Evaluate Recombinant Human TRAIL-Trimer Fusion Protein, SCB-313, in Combination with IAP Antagonist, APG-1387 for the Treatment of Peritoneal Carcinomatosis
by adminby adminSummary : Clover Biopharmaceuticals, Ltd. (Clover; Stock Code: 2197.HK), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates and…
-
Covid DrugsGlobal Market
Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vaccine Candidate VLA2001
by adminby adminSummary: -Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today confirms the previously communicated timelines of its clinical trials…